Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.
Accepted for publication March 25, 2023.
Supported by the Eye Tumor Research Foundation, Philadelphia, PA (CLS) and by the Victoria Cohen Eye Cancer Charitable Trust (VSV). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the article. Carol L. Shields, M.D. has had full access to all the data in the study and takes responsibility for the integrity of the data.
The authors have no conflicts of interest to disclose.
Address correspondence and reprint requests to Carol L. Shields, M.D., Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107. E-mail: [email protected]